Application and Funding Trends in Fiscal Year 2019

On December 20, 2019, the Further Consolidated Appropriations Act, 2020 , was signed into law. The appropriation provides NIGMS with a budget of $2,937,218,000 in Fiscal Year (FY) 2020, a 2.2% increase over the FY 2019 appropriation. With this increased budget, NIGMS is committed to providing taxpayers with the best possible returns on their investments in fundamental biomedical research [PDF]. As part of this commitment to stewardship [PDF], we regularly monitor trends in our funding portfolio. NIGMS maintains a diversified investment portfolio, supporting a wide range of research topics and investigators. Recent NIGMS and NIH programs and policies aim to increase the number of different investigators funded, and to maintain researchers’ funding stability over time. Consistent with our focus on supporting a broad group of investigators, we monitor two statistics that describe our investigator pool. One statistic that captures investigators’ success with obtaining funding is the cumulative investigator rate. This value represents the percentage of investigators who held funding in a given fiscal year relative to those actively seeking funding at some point in that fiscal year or in the previous 4 fiscal years. Figure 1 depicts the cumulative investigator rate (gray line) for NIGMS R01 and R35 applicants, from FY 2008 to FY 2019. In FY 2019, the cumulative investigator rate (41.2%) increased for the sixth consecutive year. This rise comes as a result of a de...
Source: NIGMS Feedback Loop Blog - National Institute of General Medical Sciences - Category: Biomedical Science Authors: Tags: Director’s Messages Funding Trends Funding Outcomes Funding Policies MIRA NIGMS Strategic Plan R01 Source Type: blogs